(Philadelphia, PA) - Shiriki Kumanyika, PhD, MPH, has been elected to a one year term as a member of the Board of Trustees of the International Society on Hypertension in Blacks (ISHIB), effective July, 2001.

Kumanyika is the associate dean for Health Promotion and Disease Prevention at the University of Pennsylvania School of Medicine, where she is also a professor of epidemiology, a senior scholar in the Center for Clinical Epidemiology and Biostatistics, and a senior fellow of Penn's Institute on Aging.

Headquartered in Atlanta, GA, ISHIB is a nonprofit, professional society of more than 800 members worldwide. It was founded in 1986 to respond to the disproportionate rate of high blood pressure and cardiovascular risk factors present in ethnic populations. Today it has expanded its scope to include diabetes, stroke, lipid disorders, and renal disease.
These issues are addressed through accredited professional medical education programs, research activities, and patient and community education.

Kumanyika is the author of numerous research articles, many of which focus on the problems of obesity and overweight in minority populations. She has served on various national advisory committees, including the U.S. Dietary Guidelines Committees, the National Heart, Lung, and Blood Institute Advisory Council, and the Women's Health Initiative Advisory committees. Kumanyika is a past Chair of the Food and Nutrition Section of the American Public Health Association and the Council on Epidemiology and Prevention of the American Heart Association. She currently serves on the Institute of Medicines, Food and Nutrition Board, as well as the National Board of Directors of the American Heart Association. Kumanyika is also a member of the editorial board for Ethnicity & Disease, ISHIB's international journal, which deals with disease and health patterns among ethnic minority populations.

As a member of the Board of Trustees, Kumanyika will assume a leadership position, working to help eliminate health disparities found in ethnic populations.


# # #

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.